ALNYLAM LICENSES INTELLECTUAL PROPERTY FROM COLD SPRING

摘要

Alnylam Pharmaceuticals,Inc.,Cambridge,Mass.,a leading RNAi therapeutics company,has signed a licensing agreement with Cold Spring Harbor Laboratory for intellectual property related to the induction of gene silencing in mammalian cells through RNAi.The licensing of this intellectual property extends the leadership position Alnylam has built in the fundamental patents,technology,and know-how that underlie the discovery,development and commercialization of RNAi therapeutics.